Cerasorb reliable bone graft substitute with low complication rates for curettage of bone tumors
Artificial bone graft substitutes (ABGS) for curettage of bone tumors are becoming increasingly popular. Ulrike Susanne Wittig et al conducted a retrospective analysis to determine the efficacy of the ABGS Cerasorb (Curasan-AG, Kleinostheim, Germany), a beta-tricalcium phosphate (beta-TCP), concerning resorption profile, bone healing, and remodeling after surgery and to evaluate potential complications. The study has […]